FGFR1 expression defines clinically distinct subtypes in pancreatic cancer.

Farhan HaqYou-Na SungInkeun ParkMahmood Akhtar KayaniFaizah YousufSeung-Mo HongSung-Min Ahn

Published in: Journal of translational medicine (2018)

FGFR1 expression, as estimated by IHC, may be used to define clinically distinct subtypes in pancreatic cancer. Moreover, FGFR1-based subclassification of pancreatic cancer may lead to new therapeutic approaches for the FGFR1-positive subtype.

Keyphrases

poor prognosis
long non coding rna